Loading clinical trials...
Loading clinical trials...
A Randomized, Controlled Trial Investigating the Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With a Reduced Ejection Fraction With Limited Standardized Kidney Function Assessments (RESUME-HF-Kidney)
Conditions
Interventions
Blinded kidney function assessments
Locations
2
Netherlands
Onze Lieve Vrouwe Gasthuis
Amsterdam, North Holland, Netherlands
Frisius MC
Leeuwarden, Provincie Friesland, Netherlands
Start Date
April 1, 2026
Primary Completion Date
January 1, 2030
Completion Date
January 1, 2030
Last Updated
December 18, 2025
NCT07083011
NCT07550790
NCT07037459
NCT06148935
NCT06874556
NCT06741436
Lead Sponsor
University Medical Center Groningen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions